Differential Effect of CTLA4Ig on Murine Graft-Versus-Host Disease (GVHD) Development: CTLA4Ig Prevents Both Acute and Chronic GVHD Development but Reverses only Chronic GVHD

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4258-4267

  Via, Charles S ^a   Rus, Violetta ^a   Nguyen, Phuong ^a   Linsley, Peter ^b   Gause, William C ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ALLOANTIGEN; ANTIBODY CONJUGATE; AUTOANTIBODY; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ACUTE DISEASE; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHRONIC DISEASE; CYTOLOGY; DBA MOUSE; DRUG EFFECT; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; CHRONIC DISEASE; GRAFT VS HOST DISEASE; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RECOMBINANT FUSION PROTEINS; SPLEEN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 0030293633     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
2. Linsley, P., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
3. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
4. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
5. + T lymphocytes from TCR transgenic mice. J. Immunol. 152:5220.
6. McArthur, J. G., and D. H. Raulet. 1993. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J. Exp. Med. 178:1645.
7. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
8. Lichtman, A. H., J. Chin, J. A. Schmidt, and A. K. Abbas. 1988. Role of interleukin 1 in the activation of T lymphocytes. Proc. Natl. Acad. Sci USA 85:9699.
9. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
10. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R.-Q. Wei, M. L. Gibson, X.-G. Zheng, S. Myrdal, D. Gordon, T. Bailey, S. F. Bolling, and C. B. Thompson. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci USA 89:11102.
11. Lin, H., S. F. Bolling, P. S. Linsley, R. Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med 178:1801.
12. Lu, P., X. di Zhou, S.-J. Chen, M. Moorman, S. C. Morris, F. D. Finkelman, P. S. Linsley, J. F. Urban, Jr., and W. C. Gause. 1995. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med. 180:693.
13. Lu, P., X. Zhou, S. J. Chen, M. Moorman, A. Schoneveld, S. Morris, F. D. Finkelman, P. Linsley, E. Claassen, and W. C. Gause. 1995. Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo response. J. Immunol. 154:1078.
14. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.
15. Khoury, S. J., E. A. Akalin, A. Chandraker, L. A. Turka, P. S. Linsley, M. Sayegh, and W. W. Hancock. 1995. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155:4521.
16. Gleichmann, E., S. T. Pals, A. G. Rolink, T. Radaszkiewicz, and H. Gleichmann. 1984. Craft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 5:324.
17. Via, C. S., and G. M. Shearer. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9:207.
18. De Wit, D., M. Van Mechelen, C. Zanin, J. M. Doutrelepont, T. Velu, C. Gerard, D. Abramowicz, J. Scheerlinck, P. De Baetselier, J. Urbain, O. Leo, M. Goldman, and M. Moser. 1993. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150:361.
19. + T cells. J. Immunol. 155:2396.
20. Garlisi, C. G., K. J. Pennline, S. R. Smith, M. I. Siegal, and S. P. Umland. 1993. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol. Immunol. 30:669.
21. Via, C. S., S. O. Sharrow, and G. M. Shearer. 1987. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J. Immunol. 139:1840.
22. Linsley, P. S., W. Brady, M. Urnes, L. Grosmaire, K. N. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen. J. Exp. Med. 174:561.
23. Malek, T. R., R. J. Robb, and E. M. Shevach. 1983. Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. Proc. Natl. Acad. Sci. USA 80:5694.
24. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
25. Mosmann, T. R., R. L. Bond, R. L. Coffman, J. Ohara, and W. E. Paul. 1986. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83:5654.
26. Unkeless, J. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
27. Svetic, A., F. D. Finkelman, C. Jian, C. W. Dieffenbach, D. E. Scott, K. F. McCarthy, A. D. Steinberg, and W. C. Gause. 1991. Cytokine gene expression following in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391.
28. Via, C. S. 1991. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease. J. Immunol. 146:2603.
29. Via, C. S., P. H. Nguyen, and V. Rus. 1993. Kinetics of cell surface memory marker expression in lupus-like graft-vs-host disease. J. Immunol. 150:82A (Abstr.).
30. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigens and its ligand. Annu. Rev. Immunol. 12:881.
31. Pals, S. T., T. Radaszkiewicz, and E. Gleichmann. 1984. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD. J. Immunol. 132:1669.
32. Shearer, G. M., and R. B. Levy. 1983. Graft-vs-host-associated immune suppression is activated by recognition of allogeneic murine I-A antigens. J. Exp. Med. 157:936.
33. + T helper cell function. J. Immunol. 138:1355.
34. + T cells and defective antibody production in vivo. J. Exp. Med. 179:809.
35. Gribben, J. G., G. J. Freeman, V. A. Boussiotis, P. Rennert, C. L. Jellis, E. Greenfield, M. Barber, V. A. Restivo, Jr., X. Ke, G. S. Gray, and L. M. Nadler. 1995. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92:811.
36. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
37. Azuma, M., M. Cayabyab, J. H. Phillips, and L. L. Lanier. 1993. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150:2091.
38. 1 recipients carrying mutations at H-2K and/or I-A. J. Exp. Med. 157:755.
39. Hakim, F. T., R. Cepeda, G. S. Gray, C. H. June, and R. Abe. 1995. Acute graft-versus-host reaction can be aborted by blockade of costimulatory molecules. J. Immunol. 155:1757.
40. + cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig. J. Immunol. 156:1262.
41. Blazar, B. R., P. A. Taylor, P. S. Linsley, and D. A. Vallera. 1994. In vivo blockade of CD28/CTLA4:B7/BB1 interaction with CTLA4Ig reduces lethal murine graft-versus host disease across the major histocompatibility complex barrier in mice. Blood 83:3815.
42. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
43. Thompson, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979.
44. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 80:707.
45. Perrin, P. J., D. Scott, L. Quigley, P. S. Albert, O. Feder, G. S. Gray, R. Abe, C. H. June, and M. K. Racke. 1995. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1481.
46. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Locksley. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishnaniasis. J. Immunol. 153:4142.
47. de Boeur, M., A. Kasran, J. Kwekkeboom, H. Walter, P. Vandenberghe, and J. L. Ceuppens. 1993. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23:3120.
48. Finck, B. K., P. S. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225.
49. Milich, D. R., P. S. Linsley, J. L. Hughes, and J. E. Jones. 1994. Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model. J. Immunol. 153:429.